LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Statistics

Total Valuation

LBRX has a market cap or net worth of $615.78 million. The enterprise value is $324.14 million.

Market Cap	615.78M
Enterprise Value	324.14M

Important Dates

The next estimated earnings date is Saturday, May 9, 2026, before market open.

Earnings Date	May 9, 2026
Ex-Dividend Date	n/a

Share Statistics

LBRX has 25.30 million shares outstanding. The number of shares has increased by 2,145.81% in one year.

Current Share Class	25.30M
Shares Outstanding	25.30M
Shares Change (YoY)	+2,145.81%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	61.63%
Float	13.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.04
P/TBV Ratio	2.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 41.44, with a Debt / Equity ratio of 0.01.

Current Ratio	41.44
Quick Ratio	39.67
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -15.70% and return on invested capital (ROIC) is -11.23%.

Return on Equity (ROE)	-15.70%
Return on Assets (ROA)	-10.64%
Return on Invested Capital (ROIC)	-11.23%
Return on Capital Employed (ROCE)	-9.66%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$933,519
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, LBRX has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	24.13
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.51
Average Volume (20 Days)	292,460

Short Selling Information

The latest short interest is 2.71 million, so 10.72% of the outstanding shares have been sold short.

Short Interest	2.71M
Short Previous Month	2.62M
Short % of Shares Out	10.72%
Short % of Float	20.05%
Short Ratio (days to cover)	11.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.50M
Pretax Income	-25.20M
Net Income	-25.21M
EBITDA	-29.18M
EBIT	-29.50M
Earnings Per Share (EPS)	-$3.13

Balance Sheet

The company has $295.21 million in cash and $3.57 million in debt, with a net cash position of $291.64 million or $11.53 per share.

Cash & Cash Equivalents	295.21M
Total Debt	3.57M
Net Cash	291.64M
Net Cash Per Share	$11.53
Equity (Book Value)	301.31M
Book Value Per Share	11.91
Working Capital	300.99M

Cash Flow

In the last 12 months, operating cash flow was -$35.21 million and capital expenditures -$52,000, giving a free cash flow of -$35.26 million.

Operating Cash Flow	-35.21M
Capital Expenditures	-52,000
Depreciation & Amortization	321,000
Net Borrowing	n/a
Free Cash Flow	-35.26M
FCF Per Share	-$1.39

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,145.81%
Shareholder Yield	-2,145.81%
Earnings Yield	-4.09%
FCF Yield	-5.73%

Analyst Forecast

The average price target for LBRX is $47.00, which is 93.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$47.00
Price Target Difference	93.10%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1